Interferon Current Events | Interferon News | 5
|
| Page
5 of
6 |
119 Results |
|
|
|
Sort By:
Page Views | Date |
New gene regulation mechanism discovered
Researchers at Cold Spring Harbor Laboratory have discovered a new kind of messenger RNA molecule that is converted from non-protein coding status to protein coding status in response to cellular stress such as viral infection. view more (2005-10-21)
Molecular 'on/off switch' controls immune defenses against viruses
Much like flipping a light switch, the hepatitis C virus turns on human immune defenses upon entering the body but also turns off those defenses by manipulating interaction of key cellular proteins, UT Southwestern Medical Center researchers have found. view more (2006-12-26)
When The Cause Of Depression Is A Medication
Two researchers affiliated with the University of Verona have reviewed the literature on depression caused by medications in an article published in the July-August issue of Psychotherapy and Psychosomatics. Certain medications may contribute to the etiology of depressive symptoms and disorders. Research in this area, however, has been hampered by... view more... (2004-06-22)
New protein vital for immune response is found
A newly discovered protein not only is vital to the immune system's ability to fight off viral infections but also has been found in an unexpected location within the cell, causing researchers to rethink previous notions about the workings of the human immune system. view more (2005-08-26)
Interferon-treated hepatitis C patients likely to experience retinopathy
Persons with chronic hepatitis C being treated with Interferon (IFN) are at risk of developing retinopathy as early as two weeks into treatment according to the results of a new study published in the January 2007 issue of Investigative Ophthalmology & Visual Science (IOVS). view more (2007-01-04)
Researchers have discovered a gene that can block the spread of HIV
A team of researchers at the University of Alberta, including a scientist at the University of Pennsylvania, have discovered a gene that is able to block HIV, and thought to in turn prevent the onset of AIDS. view more (2008-02-29)
Treating MS is expensive, but cost falls over time
The cost of drug treatment multiple sclerosis is high, but decreases with prolonged treatment up to 20 years, concludes a study in this week's BMJ. Researchers evaluated the cost effectiveness of four drugs currently licensed for the treatment of multiple sclerosis in the United Kingdom (three interferon betas and glatiramer acetate). They... view more... (2003-03-05)
Best treatment for MS may depend on disease subtype
Animal studies by University of Michigan scientists suggest that people who experience the same clinical signs of multiple sclerosis (MS) may have different forms of the disease that require different kinds of treatment. view more (2008-07-02)
New drug helps hepatitis C patients start antiviral therapy
A new drug that stimulates the production of blood platelets can enable patients infected with hepatitis C virus to take other antiviral medications they previously could not take to fight the disease, according to the results of a clinical trial led by a Duke University Medical Center researcher. view more (2006-10-31)
Over-the-Counter Arthritis Drug Glucosamine Might Also Help Against MS
Glucosamine, the over-the counter natural product that has been touted to help with joint and cartilage problems associated with arthritis, may also provide some relief to individuals with multiple sclerosis (MS), a degenerative, nervous system disease with no known cure. view more (2005-11-29)
Disease-modifying therapy in multiple sclerosis
Major pan-European survey shows treatment is still delayed A major pan-European survey[1,2] of over 300 neurologists in seven EC countries (France, Germany, Italy, the Netherlands, Spain, Sweden and the UK) has revealed that, on average, disease-modifying beta interferon treatment for multiple sclerosis (MS) is not initiated until a patient has... view more... (2002-08-21)
A new pharmaceutical drug that halts progress of metastatic kidney cancer
Research has shown the efficacy of a pharmaceutical drug known as sunitinib which halts progress of metastatic kidney cancer. view more (2007-03-02)
Response to immune protein determines pathology of multiple sclerosis
New research may help reveal why different parts of the brain can come under attack in patients with multiple sclerosis (MS). According to a new study in mice with an MS-like disease, the brain's response to a protein produced by invading T cells dictates whether it's the spinal cord or cerebellum that comes under fire. view more (2008-10-14)
Hyperferritinemia is another surrogate marker of advanced liver disease
High serum ferritin, being a hallmark of hereditary hemochromatosis , is frequently found in chronic hepatitis C, alcoholic or non-alcoholic steatohepatitis and non-alcoholic fatty liver disease patients. view more (2009-05-13)
Mild hepatitis C infection will rapidly worsen in one in three people affected
Mild hepatitis C infection will rapidly worsen in one in three of those affected, suggests research in Gut. This is particularly likely in those who are older when first infected, and those who already have a degree of inflammation and scar tissue (fibrosis) in their liver at diagnosis. The viral liver infection hepatitis C (HCV) is mainly passed... view more... (2004-02-11)
Team identifies a molecular switch linking infectious disease and depression
Researchers at the University of Illinois report that IDO, an enzyme found throughout the body and long suspected of playing a role in depression, is in fact essential to the onset of depressive symptoms sparked by chronic inflammation. view more (2009-04-01)
New combination therapy safe, promising for melanoma patients
The combination of two different biotherapies may be beneficial for patients with inoperable melanoma, according to a University of Pittsburgh Cancer Institute (UPCI) study presented at the 44th annual meeting of the American Society of Clinical Oncology (ASCO) in Chicago. view more (2008-06-02)
Hepatitis C Treatment Reduces the Virus but Liver Damage Continues
Treating patients who have chronic hepatitis C and advanced liver disease with long-term pegylated interferon significantly decreased their liver enzymes, viral levels and liver inflammation, but the treatment did not slow or prevent the progression of serious liver disease, a study finds. view more (2008-12-10)
Early treatment is key to combating hepatitis C virus
Canadian researchers have shown that patients who receive early treatment for Hepatitis C virus (HCV) within the first months following an infection, develop a rapid poly-functional immune response against HCV similar to when infection is erradicted spontaneously, according to a new study published in the Journal of Virology. view more (2008-08-11)
How to select anti-hepatitis B virus agents for drug-resistance patients?
HBV infection may lead to acute liver disease, chronic active hepatitis, liver cirrhosis, and hepatocellular carcinoma. Over 350 million people worldwide are estimated to be infected chronically by HBV and are therefore at risk of liver failure, cirrhosis, or hepatocellular carcinoma. view more (2008-09-25)
|
|
| Page
5 of
6 |
119 Results |
|
|
|
Sort By:
Page Views | Date |
|
